Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
11.17 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 9.76 - 28.42 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 11.17 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
406.56M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 10.59 | 11.18 | 9.76 | 10.30 | 582,341 | 0.58 | 5.48% |
1 Month | 12.30 | 13.30 | 9.76 | 10.87 | 636,497 | -1.13 | -9.19% |
3 Months | 16.66 | 16.79 | 9.76 | 12.68 | 515,083 | -5.49 | -32.95% |
6 Months | 17.10 | 22.64 | 9.76 | 15.97 | 531,790 | -5.93 | -34.68% |
1 Year | 27.56 | 28.42 | 9.76 | 18.54 | 541,864 | -16.39 | -59.47% |
3 Years | 143.98 | 182.45 | 9.76 | 52.35 | 550,268 | -132.81 | -92.24% |
5 Years | 62.48 | 188.14 | 9.76 | 74.90 | 489,823 | -51.31 | -82.12% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |